Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29401 - 29425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	ADAMDEC1	27299	upregulated	decitabine results in increased expression of ADAMDEC1 mRNA	8p21.2	A21915
Decitabine	Approved Investigational	ADAMTS1	9510	upregulated	decitabine results in increased expression of ADAMTS1 mRNA	21q21.3	A21916
Decitabine	Approved Investigational	ADRA2A	150	upregulated	decitabine results in increased expression of ADRA2A mRNA	10q25.2	A20985
Decitabine	Approved Investigational	AGPAT2	10555	upregulated	decitabine results in increased expression of AGPAT2 mRNA	9q34.3	A21917
Decitabine	Approved Investigational	AHR	196	downregulated	decitabine results in decreased expression of AHR mRNA	7p21.1	A21918
Decitabine	Approved Investigational	AHRR	57491	upregulated	decitabine results in increased expression of AHRR mRNA	5p15.33	A21918
Decitabine	Approved Investigational	ALDH1A3	220	upregulated	decitabine results in increased expression of ALDH1A3 mRNA	15q26.3	A21919 A21915
Decitabine	Approved Investigational	ALDH2	217	upregulated	decitabine results in increased expression of ALDH2 mRNA	12q24.12	A20985
Decitabine	Approved Investigational	ALDH6A1	4329	downregulated	decitabine results in decreased expression of ALDH6A1 mRNA	14q24.3	A21913
Decitabine	Approved Investigational	ALDOC	230	upregulated	decitabine results in increased expression of ALDOC mRNA	17q11.2	A21917
Decitabine	Approved Investigational	ALX4	60529	upregulated	decitabine results in increased expression of ALX4 mRNA	11p11.2	A21920
Decitabine	Approved Investigational	AMH	268	downregulated	decitabine results in decreased expression of AMH mRNA	19p13.3	A21913
Decitabine	Approved Investigational	ANGPT2	285	upregulated	decitabine results in increased expression of ANGPT2 mRNA	8p23.1	A21915
Decitabine	Approved Investigational	ANGPTL4	51129	upregulated	decitabine results in increased expression of ANGPTL4 mRNA	19p13.2	A21917
Decitabine	Approved Investigational	ANOS1	3730	upregulated	decitabine results in increased expression of ANOS1 mRNA	Xp22.31	A21912
Decitabine	Approved Investigational	ANPEP	290	upregulated	decitabine results in increased expression of ANPEP mRNA	15q26.1	A20985
Decitabine	Approved Investigational	ANXA5	308	upregulated	decitabine results in increased expression of ANXA5 mRNA	4q27	A21919
Decitabine	Approved Investigational	AP1S1	1174	upregulated	decitabine results in increased expression of AP1S1 mRNA	7q22.1	A21917
Decitabine	Approved Investigational	AP1S2	8905	upregulated	decitabine results in increased expression of AP1S2 mRNA	Xp22.2	A20985
Decitabine	Approved Investigational	APAF1	317	upregulated	decitabine results in increased expression of APAF1 mRNA	12q23.1	A21921 A21922
Decitabine	Approved Investigational	APLP2	334	upregulated	decitabine results in increased expression of APLP2 mRNA	11q24.3	A21917
Decitabine	Approved Investigational	APOBEC3F	200316	upregulated	decitabine results in increased expression of APOBEC3F mRNA	22q13.1	A20985
Decitabine	Approved Investigational	AR	367	upregulated	decitabine results in increased expression of AR mRNA	Xq12	A21923 A21924
Decitabine	Approved Investigational	AREG	374	upregulated	decitabine results in increased expression of AREG mRNA	4q13.3	A21919 A21915
Decitabine	Approved Investigational	ARHGAP45	23526	upregulated	decitabine results in increased expression of ARHGAP45 mRNA	19p13.3	A21925

Displaying entries 29401 - 29425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability